168 related articles for article (PubMed ID: 6339411)
21. A Mesocosm of Lactobacillus johnsonii, Bifidobacterium longum, and Escherichia coli in the mouse gut.
Denou E; Rezzonico E; Panoff JM; Arigoni F; Brüssow H
DNA Cell Biol; 2009 Aug; 28(8):413-22. PubMed ID: 19534605
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of Escherichia coli F-18Col- type-1 fimbriae synthesis by leuX.
Newman JV; Burghoff RL; Pallesen L; Krogfelt KA; Kristensen CS; Laux DC; Cohen PS
FEMS Microbiol Lett; 1994 Oct; 122(3):281-7. PubMed ID: 7988869
[TBL] [Abstract][Full Text] [Related]
23. The lipopolysaccharide of escherichia coli C- studies on the anomeric configurations of the hexoses in the R1 core.
Feige U
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):52-62. PubMed ID: 7032152
[TBL] [Abstract][Full Text] [Related]
24. Survival and implantation of Escherichia coli in the intestinal tract.
Freter R; Brickner H; Fekete J; Vickerman MM; Carey KE
Infect Immun; 1983 Feb; 39(2):686-703. PubMed ID: 6339389
[TBL] [Abstract][Full Text] [Related]
25. Outer membrane proteins of Escherichia coli. 3. Evidence that the major protein of Escherichia coli O111 outer membrane consists of four distinct polypeptide species.
Schnaitman CA
J Bacteriol; 1974 May; 118(2):442-53. PubMed ID: 4208134
[TBL] [Abstract][Full Text] [Related]
26. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine.
Miranda RL; Conway T; Leatham MP; Chang DE; Norris WE; Allen JH; Stevenson SJ; Laux DC; Cohen PS
Infect Immun; 2004 Mar; 72(3):1666-76. PubMed ID: 14977974
[TBL] [Abstract][Full Text] [Related]
27. Effect of the Escherichia coli EMO strain on experimental infection by Salmonella enterica serovar Typhimurium in gnotobiotic mice.
Lima-Filho JV; Vieira LQ; Arantes RM; Nicoli JR
Braz J Med Biol Res; 2004 Jul; 37(7):1005-13. PubMed ID: 15264007
[TBL] [Abstract][Full Text] [Related]
28. Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice.
McCormick BA; Stocker BA; Laux DC; Cohen PS
Infect Immun; 1988 Sep; 56(9):2209-17. PubMed ID: 3044995
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of lipopolysaccharides. Analysis of polysaccharide chain lengths by sodium dodecylsulfate-polyacrylamide gel electrophoresis.
Jann B; Reske K; Jann K
Eur J Biochem; 1975 Dec; 60(1):239-46. PubMed ID: 1107034
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
31. Properties of Escherichia coli grown in vivo using a chamber implant system.
Finn TM; Arbuthnott JP; Dougan G
J Gen Microbiol; 1982 Dec; 128(12):3083-91. PubMed ID: 6820803
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab).
Laux DC; McSweegan EF; Williams TJ; Wadolkowski EA; Cohen PS
Infect Immun; 1986 Apr; 52(1):18-25. PubMed ID: 3007359
[TBL] [Abstract][Full Text] [Related]
33. Competition between congenic Escherichia coli K-12 strains in vivo.
Onderdonk A; Marshall B; Cisneros R; Levy SB
Infect Immun; 1981 Apr; 32(1):74-9. PubMed ID: 7012037
[TBL] [Abstract][Full Text] [Related]
34. Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins.
Hoskins LC; Agustines M; McKee WB; Boulding ET; Kriaris M; Niedermeyer G
J Clin Invest; 1985 Mar; 75(3):944-53. PubMed ID: 3920248
[TBL] [Abstract][Full Text] [Related]
35. Pathogenicity of Escherichia coli O115:K"V165" strains isolated from pigs with diarrhea.
Fairbrother JM; Broes A; Jacques M; Larivière S
Am J Vet Res; 1989 Jul; 50(7):1029-36. PubMed ID: 2672911
[TBL] [Abstract][Full Text] [Related]
36. Prevention of drug-resistant Escherichia coli colonization in chickens by treatment with a faecal fluid.
Nakamura M; Yoshimura H; Koeda T; Sato S
J Appl Bacteriol; 1983 Oct; 55(2):225-31. PubMed ID: 6197400
[TBL] [Abstract][Full Text] [Related]
37. Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.
Goldman RC; Joiner K; Leive L
J Bacteriol; 1984 Sep; 159(3):877-82. PubMed ID: 6207166
[TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide heterogeneity in Escherichia coli J5 variants: analysis by flow cytometry.
Evans ME; Pollack M; Koles NL; Hardegen NJ; Panopoulos D
J Infect Dis; 1992 Oct; 166(4):803-11. PubMed ID: 1527415
[TBL] [Abstract][Full Text] [Related]
39. Comparison of an espB gene fecal polymerase chain reaction assay with bacteriologic isolation for detection of Citrobacter rodentium infection in mice.
McKeel R; Douris N; Foley PL; Feldman SH
Comp Med; 2002 Oct; 52(5):439-44. PubMed ID: 12405637
[TBL] [Abstract][Full Text] [Related]
40. Age-related resistance to 987P fimbria-mediated colonization correlates with specific glycolipid receptors in intestinal mucus in swine.
Dean-Nystrom EA; Samuel JE
Infect Immun; 1994 Nov; 62(11):4789-94. PubMed ID: 7927756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]